TABLE 3.
Secondary efficacy endpoints.
| Parameter | Control group (n = 42) | Pentoxifylline group (n = 46) | P-value |
|---|---|---|---|
| Patients needed rescue analgesia, n (%) | 5 (11.6) | 0 (0) | 0.02 b |
| Complication incidence, n (%) | 8 (19.0) | 1 (2.2) | 0.01 b |
| Type of complication, n (%) | |||
| Infection | 2 (4.8) | 0 (0.0) | 0.06 b |
| Seroma | 3 (7.1) | 1 (2.2) | |
| Wound dehiscence | 3 (7.1) | 0 (0.0) | |
| Time for suture removal (days), mean ± SD | 19.3 ± 6.7 | 15.0 ± 4.4 | 0.001 a |
Student’s t-test.
Pearson Chi square.